Literature DB >> 16687092

[Quantum dots and their applications in cancer research].

Liang-Dong Chen1, Yan Li, Hong-Yin Yuan, Dai-Wen Pang.   

Abstract

Quantum dots are semiconductor nanocrystals with physical dimensions smaller than the exciton Bohr radius. As their fluorescence emissions are size-tunable, we can acquire any spectrum from ultraviolet (UV) to near-infrared by changing the particles' radiuses. The large Stokes shifts of quantum dots can be used to further improve detection sensitivity. The luminescence intensity is high and stable. Single quantum dots have longer excited state lifetimes, and they appear 10-20 times brighter than organic fluorescent dyes. And they have good biocompatibility because quantum dots with appropriate shells don't interfere with physiological processes, such as growth, development, signaling and motility. With the development of optical labeling and imaging technology, many present conventional biomedical methods have limitations in microcosmic direct real-time researches of bio-molecular interactions and early diagnosis of malignant tumors. The invention of quantum dots and their biomedical applications make them as good markers for tumor cell tracing and targeting in cancer research, such as prostate cancer, mammary cancer, cervical cancer, basal cell carcinoma, liver cancer, and melanoma. The current research is focused on tumor markers imaging and molecular interaction based on tangible carriers such as cells and tissues. The next research orientation would be to tap the potential of this highly sensitive technology to image tumor biomarkers in serum and other body fluids, so as to increase the early diagnosis rate of malignant tumors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16687092

Source DB:  PubMed          Journal:  Ai Zheng


  2 in total

1.  Effects of integrin-targeted photodynamic therapy on pancreatic carcinoma cell.

Authors:  Min Zhou; Qian-Wen Ni; Shan-Ying Yang; Chun-Ying Qu; Peng-Cheng Zhao; Jian-Cheng Zhang; Lei-Ming Xu
Journal:  World J Gastroenterol       Date:  2013-10-21       Impact factor: 5.742

Review 2.  CD44-Targeted Nanocarrier for Cancer Therapy.

Authors:  Prashant Kesharwani; Rahul Chadar; Afsana Sheikh; Waleed Y Rizg; Awaji Y Safhi
Journal:  Front Pharmacol       Date:  2022-03-31       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.